Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database
Devalkumar J. Rajyaguru(Gundersen Health System), Ronald S. Go(Mayo Clinic), Mark J. Truty(Mayo Clinic in Arizona), Andrew J. Borgert(Gundersen Health System), Þorvarður R. Hálfdánarson(Mayo Clinic), Angela Smith(Gundersen Health System), A. Nicholas Kurup(Gundersen Health System), Patrick D. Conway(Gundersen Health System), R Thomes(Gundersen Health System)
Cited by 195
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Review of the Comparative Pharmacology and Clinical Activity of Cisplatin and Carboplatin
|Journal of Clinical Oncology|1999|697